Response to mason and drakeman's commentary on “fishing for sharks: Partner selection in biopharmaceutical R&D alliances”



We respond to Mason and Drakeman's comment on our published paper titled “Are All ‘Sharks’ Dangerous? New Biotechnology Ventures and Partner Selection in R&D Alliances” (Diestre and Rajagopalan, 2012). We discuss both their survey analysis and alternative explanation and conclude that neither of them invalidates our theoretical premise and our empirical conclusions. Copyright © 2014 John Wiley & Sons, Ltd.